Olink announces availability of new findings on human proteome from UKB

Olink announced the availability of new findings into the variability of the human proteome, based on measurements of approximately 1,500 proteins in over 50,000 participants from the UK Biobank, UKB. In April 2023, over 50,000 samples from UKB, analyzed on the Olink platform, were released to the scientific community as the largest collection of proteomic data to date. The first addition of normal protein ranges based on the UKB data on Olink Insight contains data on approximately 1,500 proteins, while the second phase release will cover up to ~ 3,000 proteins. “The large-scale UKB cohort gives scientists a clear view into the normal variability of protein levels in humans, providing an invaluable resource guiding informed decisions in their research,” said Markus Sallman Almen, Chief Data and Analytics Officer, Olink. “This release of high-quality protein biomarker data, along with proper analysis and visualization, is a major step forward in accelerating the adoption of proteomics in the research community and our understanding of the dynamic plasma proteome. We look forward to the discoveries that will come now that the UKB data is available to the wider scientific community.”